Last reviewed · How we verify
NCT03291769
Effects of Intraoperative Blood and Blood Product Consumption on Postoperative Results in Pediatric Cardiac Surgery
trial in Blood Loss, Surgical in 83 participants. Completed in 25 December 2018.
25 August 2018
Quick facts
| Lead sponsor | Cukurova University |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 83 |
| Start date | 25 March 2018 |
| Primary completion | 25 August 2018 |
| Estimated completion | 25 December 2018 |
| Sites | 1 location across Turkey (Türkiye) |
Conditions studied
- Blood Loss, Surgical — all drugs for Blood Loss, Surgical →
- Pediatric Heart Surgery — all drugs for Pediatric Heart Surgery →
Sponsor
Cukurova University
Who can join
Adults 1 Day to 16, any sex, with Blood Loss, Surgical or Pediatric Heart Surgery. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Blood products and intravenous fluids are frequently used in the treatment of children who have undergone cardiac surgery in order to maintain hemodynamic stability. Optimal hematocrit values during CPB are still being discussed in children undergoing congenital cardiac surgery. The overall complication rate for transfusion in adults is 2.5 complications per 1000 units, while 10.7 complications per 1000 transfusion in children. The aim of this study is to investigate the effects of the our transfusion strategies used in pediatric cardiac surgery on duration of intensive care unit, duration of postoperative mechanical ventilation and mortality.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03291769
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Blood Loss, Surgical
Currently open trials in the same condition.
- NCT06637137 — Patient Blood Management in Patients Scheduled for Cardiac Surgery · recruiting
- NCT06725732 — Assessment of Nebulized Tranexamic Acid in Functional Endoscopic Sinus Surgery Using Modena Bleeding Score · EARLY_PHASE1 · recruiting
- NCT06428682 — Role of TXA in Patients Undergoing Breast Free Flap Reconstruction · Phase 4 · recruiting
- NCT06601582 — Effectiveness of a Intraoperative Blood Recovery System in Cardiovascular Surgery in Brazil · NA · recruiting
- NCT05077124 — Safe and Timely Antithrombotic Removal (STAR) Registry · recruiting
Other Cukurova University trials
Trials by the same sponsor.
- NCT07464652 — Objectıve Structured Clınıcal Examınatıon Stress For Intravenous Perıpheral Catheterızatıon · NA · not yet recruiting
- NCT07458789 — Breastfeeding Education · NA · not yet recruiting
- NCT07346482 — Determining the Effect of Midwife-Led Safe Infant Care Training for Pregnant Women on Awareness of Sudden Infant Death S · NA · not yet recruiting
- NCT07248904 — The Effect of a Transtheoretical Model-Based Educational Intervention on First-Year Nursing Students' HPV Knowledge, Hea · NA · recruiting
- NCT07241949 — Regional Analgesia Techniques for Laparoscopic Cholecystectomy · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03291769 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Cukurova University
- Last refreshed: 17 October 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03291769.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing